See K - Search Results

1

Evaluation of sPGA × BSA as an Outcome Measure and Treatment Target for Clinical Practice.

Merola JF, Amato DA, See K, Burge R, Mallinckrodt C, Ojeh CK, Gottlieb A. Merola JF, et al. Among authors: see k. J Invest Dermatol. 2018 Sep;138(9):1955-1961. doi: 10.1016/j.jid.2018.01.041. Epub 2018 Mar 22. J Invest Dermatol. 2018. PMID: 29577919 Free article. Clinical Trial.

2

Does Teriparatide Improve Femoral Neck Fracture Healing: Results From A Randomized Placebo-controlled Trial.

Bhandari M, Jin L, See K, Burge R, Gilchrist N, Witvrouw R, Krohn KD, Warner MR, Ahmad QI, Mitlak B. Bhandari M, et al. Among authors: see k. Clin Orthop Relat Res. 2016 May;474(5):1234-44. doi: 10.1007/s11999-015-4669-z. Epub 2016 Mar 1. Clin Orthop Relat Res. 2016. PMID: 26932738 Free PMC article. Clinical Trial.

3

Continuous dosing versus interrupted therapy with ixekizumab: an integrated analysis of two phase 3 trials in psoriasis.

Blauvelt A, Papp KA, Sofen H, Augustin M, Yosipovitch G, Katoh N, Mrowietz U, Ohtsuki M, Poulin Y, Shrom D, Burge R, See K, Mallbris L, Gordon KB. Blauvelt A, et al. Among authors: see k. J Eur Acad Dermatol Venereol. 2017 Jun;31(6):1004-1013. doi: 10.1111/jdv.14163. Epub 2017 Mar 31. J Eur Acad Dermatol Venereol. 2017. PMID: 28190255 Free PMC article. Clinical Trial.

4

Improvements in psoriasis within different body regions vary over time following treatment with ixekizumab.

Blauvelt A, Muram TM, See K, Mallinckrodt CH, Crowley JJ, van de Kerkhof P. Blauvelt A, et al. Among authors: see k. J Dermatolog Treat. 2018 May;29(3):220-229. doi: 10.1080/09546634.2017.1365114. Epub 2017 Sep 29. J Dermatolog Treat. 2018. PMID: 28792259 Clinical Trial.

5

The Static Physician's Global Assessment of Genitalia: A Clinical Outcome Measure for the Severity of Genital Psoriasis.

Merola JF, Bleakman AP, Gottlieb AB, Menter A, Naegeli AN, Bissonnette R, Guenther L, Sullivan J, Meeuwis K, See K, Duffin KC. Merola JF, et al. Among authors: see k. J Drugs Dermatol. 2017 Aug 1;16(8):793-799. J Drugs Dermatol. 2017. PMID: 28809994

6

Matching-adjusted indirect comparison of efficacy in patients with moderate-to-severe plaque psoriasis treated with ixekizumab vs. secukinumab.

Warren RB, Brnabic A, Saure D, Langley RG, See K, Wu JJ, Schacht A, Mallbris L, Nast A. Warren RB, et al. Among authors: see k. Br J Dermatol. 2018 May;178(5):1064-1071. doi: 10.1111/bjd.16140. Epub 2018 Mar 1. Br J Dermatol. 2018. PMID: 29171861

7

Rapid Response of Biologic Treatments of Moderate-to-Severe Plaque Psoriasis: A Comprehensive Investigation Using Bayesian and Frequentist Network Meta-analyses.

Warren RB, See K, Burge R, Zhang Y, Brnabic A, Gallo G, Garrelts A, Egeberg A. Warren RB, et al. Among authors: see k. Dermatol Ther (Heidelb). 2020 Feb;10(1):73-86. doi: 10.1007/s13555-019-00337-y. Epub 2019 Nov 4. Dermatol Ther (Heidelb). 2020. PMID: 31686337 Free PMC article.

8

Epidemiology of psoriasis in hard-to-treat body locations: data from the Danish skin cohort.

Egeberg A, See K, Garrelts A, Burge R. Egeberg A, et al. Among authors: see k. BMC Dermatol. 2020 May 20;20(1):3. doi: 10.1186/s12895-020-00099-7. BMC Dermatol. 2020. PMID: 32434510 Free PMC article.

9

Long-term efficacy and safety of ixekizumab: A 5-year analysis of the UNCOVER-3 randomized controlled trial.

Blauvelt A, Lebwohl MG, Mabuchi T, Leung A, Garrelts A, Crane H, ElMaraghy H, Patel H, Ridenour T, See K, Gallo G, Paul C. Blauvelt A, et al. Among authors: see k. J Am Acad Dermatol. 2021 Aug;85(2):360-368. doi: 10.1016/j.jaad.2020.11.022. Epub 2020 Nov 28. J Am Acad Dermatol. 2021. PMID: 33253833 Free article. Clinical Trial.

10

Effect of Ixekizumab on Patient Reported Outcomes and Quality of Life in Patients With Moderate-to-Severe Plaque Psoriasis: 5-Year Results from the UNCOVER-1 and -2 Studies.

Gooderham MJ, Elewski B, Augustin M, Iversen L, Torii H, Burge R, See K, Gallo G, Eastman WJ, McKean-Matthews M, Foley P. Gooderham MJ, et al. Among authors: see k. J Drugs Dermatol. 2021 Apr 1;20(4):394-401. doi: 10.36849/JDD.2021.5821. J Drugs Dermatol. 2021. PMID: 33852247 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

273 results

Search Page